Skip to main content
Clinical Trials/NCT02115555
NCT02115555
Completed
Not Applicable

Advancing Diabetes Management in Adolescents Using Health Information Technology

Indiana University2 sites in 1 country129 target enrollmentMay 2014
ConditionsType 1 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 1 Diabetes
Sponsor
Indiana University
Enrollment
129
Locations
2
Primary Endpoint
Glycemic Control using HBA1C
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The study will compare three treatment strategies to look at the best clinical outcomes.

The investigator hypothesizes that the combined approach of a health information technology program plus a conflict-management contract will lead to the best outcomes.

Detailed Description

This study will compare three strategies for enhancing adherence to diabetes care in our population. The study will look at which strategy results in the best short-term clinical outcomes for the population. Also, the study will look at patient satisfaction of contact with his/her health care team, quality of life, and family dynamics. The three arms are: 1. HIT (health information technology) aided approach 2. Contracted conflict-management strategy 3. Combination of the HIT-aided approach and the contracted conflict management strategy

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
June 2016
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tamara S. Hannon

Associate Professor of Pediatrics

Indiana University

Eligibility Criteria

Inclusion Criteria

  • Type 1 diabetes diagnosed for at least 6 months
  • At least one or more parent/guardian who agrees to participate

Exclusion Criteria

  • Other chronic diseases with the exception of well-controlled asthma or treated thyroid disease

Outcomes

Primary Outcomes

Glycemic Control using HBA1C

Time Frame: Baseline, 3 months, and 6 months

Change in Glycemic Control

Secondary Outcomes

  • Frequency of self monitoring blood glucose measurement(Baseline, 3 months, 6 months)
  • Quality of Life(Baseline and 6 months)
  • Family dynamics(Baseline and 6 months)
  • Treatment Adherence Behaviors(Once per month for 6 months)

Study Sites (2)

Loading locations...

Similar Trials